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During the ongoing COVID-19 pandemic, staff shortages due to illness, self-isolation and 
redeployment have been a major challenge. Universal healthcare worker (HCW) testing is 
potentially useful in ameliorating workforce depletion and reducing asymptomatic spread of 
SARS-CoV-2. Nasopharyngeal swab polymerase chain reaction (RT-PCR) can diagnose 
only current or recent infection; testing for antibody responses against SARS-CoV-2 could 
enhance the ability to expedite reinstatement of services, while ensuring patient and staff 
safety. Tests are now available for immunoglobulin (Ig) G against the SARS-CoV-2 
nucleocapsid protein; the Abbott SARS-CoV-2 IgG ELISA is reported to have high specificity 
(99.9%) and sensitivity (96.9%).1 In London, England, HCW at the Portland Hospital for 
Women and Children are routinely swabbed for SARS-CoV-2 as part of hospital surveillance 
policy and asked to self-isolate if infected. Between May 15-28, 2020, 190 HCW who had 
previously had a nasopharyngeal swab for SARS-CoV-2, were screened for SARS-CoV-2 
IgG antibodies. Informed consent included acknowledgement that a positive result should 
not be considered an ‘immunity certificate’. 
SARS-CoV-2 IgG antibodies were detected in 41 (22%) HCWs, including all 25 [19 (76%) 
symptomatic, 6 (24%) asymptomatic] previously testing positive for SARS-CoV-2 on 
nasopharyngeal swab RT-PCR. At the same time, 16/165 (10%) HCWs who tested negative 
for SARS-CoV-2 on nasopharyngeal swab, of whom 2 (12.5%) had reported COVID-19-like 
symptoms, were positive for SARS-CoV-2 IgG. Of those positive for IgG, 39% had 
previously tested negative on nasopharyngeal swab (Figure). Risk factors associated with an 
increased risk of severe COVID-19 are included in the Figure. 
We previously reported that 32% of HCW testing positive for SARS-CoV-2 on 
nasopharyngeal swab were asymptomatic at the time.2 Symptomatic and asymptomatic 
SARS-CoV-2 positive adults have similar viral loads and infectious virus isolation.3 Our 
finding that both of these groups developed SARS-CoV-2 IgG antibodies is reassuring.  
Of those testing positive for SARS-CoV-2 IgG, 39% had an earlier negative nasopharyngeal 
swab. Possible explanations are that either infection occurred at an interval before or after 
the swab test, or the swab RT-PCR gave a false negative result (due to poor swabbing 
technique, suboptimal storage conditions, delay in testing, or poor sensitivity of 
nasopharyngeal swabs, reported to be as low as 70%).4  
The overall prevalence of SARS-CoV-2 IgG (22%) among HCW was higher than in the 
general population in London (17%) or across the UK (5%).5 Both symptomatic and 


















HCW with negative nasopharyngeal swabs, despite the majority remaining asymptomatic. 
These findings are important for modelling SARS-CoV-2 transmission among HCW. Further 
studies are needed to establish whether these antibodies protect against re-infection and the 
duration of protection. 
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